PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21428797-1	2010	BACKGROUND: Benzylamine exerts insulin-like effects in adipocytes (e.g., glucose uptake and antilipolysis) and improves glucose handling in rodents.	benzylamine	12-23	insulin	Homo sapiens	31-38	
21428797-2	2010	RESULTS: In murine adipocytes, benzylamine mimics another insulin action: it enhances apelin expression in a manner that is blocked by the semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1) inhibitor semicarbazide.	benzylamine	31-42	insulin	Homo sapiens	58-65	
21428797-6	2010	CONCLUSION: Owing to the parallelism between the in vitro insulin mimicry and the in vivo improvement of glucose handling elicited by benzylamine in rodents, the SSAO/VAP-1 substrates, with stronger effects on human adipocytes than benzylamine, show promising applications for the treatment of insulin resistance.	benzylamine	134-145	insulin	Homo sapiens	294-301	
21428797-6	2010	CONCLUSION: Owing to the parallelism between the in vitro insulin mimicry and the in vivo improvement of glucose handling elicited by benzylamine in rodents, the SSAO/VAP-1 substrates, with stronger effects on human adipocytes than benzylamine, show promising applications for the treatment of insulin resistance.	benzylamine	232-243	insulin	Homo sapiens	58-65	
15928836-0	2005	Tyramine, benzylamine, and to a lesser extent histamine, partially mimic the adipogenic effect of insulin in a human preadipocyte cell strain.	benzylamine	10-21	insulin	Homo sapiens	98-105	
16135411-0	2005	Methylamine but not mafenide mimics insulin-like activity of the semicarbazide-sensitive amine oxidase-substrate benzylamine on glucose tolerance and on human adipocyte metabolism.	benzylamine	113-124	insulin	Homo sapiens	36-43	
16135411-3	2005	Such insulin-mimicking properties are the consequence of hydrogen peroxide production during benzylamine oxidation by semicarbazide-sensitive amine oxidase (SSAO).	benzylamine	93-104	insulin	Homo sapiens	5-12